Not sure what that means but think about this for a minuet. We don't know what phase 2 trials will yield right? Right, but for some strange reason the CEO decides two weeks ago to hire a new VP and not just any VP but the former VP of ImClone the same guy that lead the company to a buy out from a major pharma he is now ADXS VP I wonder if the company though the trials were not going well why hire this guy? Now on the other hand if the trials are going great this is the perfect guy to hire he has the industry connections to seal this deal!
Then in 2012 ADXS received the Vaccine Industry Excellence Award!! For and I quote "Best Therapeutic Vaccine" keep in mind over 60% of attendees to this event come from the worlds leading pharma and biotech companies!